India link in fresh US insider trading scam
- In Delhi, Hardik Patel says he will take movement across country
- Bihar: BJP hits back, says it was not a Swabhiman rally but Apman rally
- Hindu women should never marry outside community: Sadhvi Niranjan Jyoti
- Ready to amend Land Acquisition Act, ordinance will lapse tomorrow: PM
- Sheena murder case: Suitcase seized, accused taken to Raigad forest to 'recreate' crime scene
A prominent Indian-origin hedge fund portfolio manager has been charged with participating in one of the "most lucrative" insider trading schemes ever in the US.
Mathew Martoma, 38, has been charged with using material, non-public information that he received from a doctor on the clinical trial of an Alzheimer's drug to make profits and avoid losses for his hedge fund for an amount totalling approximately $276 million.
Martoma, who was arrested last week from his home in Boca Raton, Florida, was released on Monday on a $5 million bail after a brief hearing at the Manhattan federal court here. He did not enter any plea and the judge set the next hearing for December 26.